Verbatim response from Claude
Wegovy vs Zepbound: Quick Comparison
The Drugs
Wegovy (semaglutide)
- GLP-1 receptor agonist
- ~15% average weight loss in trials
- Made by Novo Nordisk
- Weekly injection
Zepbound (tirzepatide)
- Dual GIP/GLP-1 agonist
- ~20-22% average weight loss in trials
- Made by Eli Lilly
- Weekly injection
Which to Ask For?
Zepbound has an edge for most people because:
- Stronger average weight loss in head-to-head comparisons
- Often more affordable (Lilly offers direct savings programs)
- Newer mechanism may work better for some metabolisms
Choose Wegovy if:
- You've responded well to semaglutide before
- Your insurance covers it specifically
- Your doctor recommends it for cardiac history (has FDA heart benefit data)
Where to Get Either Online
- Hims & Hers – convenient telehealth, offers both
- Ro Body – strong medical support program
- Found – good for ongoing coaching
- Eli Lilly's LillyDirect – goes directly through Lilly for Zepbound
⚠️ Important Notes
- You need a prescription regardless
- Check insurance first – both can exceed $1,000/month without coverage
- Avoid unverified compounding pharmacies